{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:01:27Z","timestamp":1790949687033,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:00:00Z","timestamp":1610236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:00:00Z","timestamp":1610236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00296-020-04779-y","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T10:03:06Z","timestamp":1610272986000},"page":"551-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-3925","authenticated-orcid":false,"given":"R.","family":"Naveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1658-8155","authenticated-orcid":false,"given":"Upendra","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,10]]},"reference":[{"key":"4779_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G et al (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48\u201355. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.001","journal-title":"J Autoimmun"},{"key":"4779_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL (2018) Autoantibodies in myositis. Nat Rev Rheumatol 14:290\u2013302. https:\/\/doi.org\/10.1038\/nrrheum.2018.56","journal-title":"Nat Rev Rheumatol"},{"key":"4779_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","volume":"23","author":"LJ Witt","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME (2016) The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med 23:218\u2013226. https:\/\/doi.org\/10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"4779_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.berh.2016.02.005","volume":"29","author":"S Colafrancesco","year":"2015","unstructured":"Colafrancesco S, Priori R, Valesini G (2015) Inflammatory myopathies and overlap syndromes: Update on histological and serological profile. Best Pract Res Clin Rheumatol 29:810\u2013825. https:\/\/doi.org\/10.1016\/j.berh.2016.02.005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4779_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/BOR.0000000000000536","volume":"30","author":"M Fredi","year":"2018","unstructured":"Fredi M, Cavazzana I, Franceschini F (2018) The clinico-serological spectrum of overlap myositis. Curr Opin Rheumatol 30:637\u2013643. https:\/\/doi.org\/10.1097\/BOR.0000000000000536","journal-title":"Curr Opin Rheumatol"},{"key":"4779_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","volume":"33","author":"LA Aguila","year":"2014","unstructured":"Aguila LA, Lopes MRU, Pretti FZ et al (2014) Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis. Clin Rheumatol 33:1093\u20131098. https:\/\/doi.org\/10.1007\/s10067-014-2730-z","journal-title":"Clin Rheumatol"},{"key":"4779_CR7","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00296-019-04411-8","volume":"39","author":"A Maundrell","year":"2019","unstructured":"Maundrell A, Proudman S, Limaye V (2019) Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies. Rheumatol Int 39:1777\u20131781. https:\/\/doi.org\/10.1007\/s00296-019-04411-8","journal-title":"Rheumatol Int"},{"key":"4779_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/jcp.54.5.340","volume":"54","author":"EC Jury","year":"2001","unstructured":"Jury EC, D\u2019Cruz D, Morrow WJW (2001) Autoantibodies and overlap syndromes in autoimmune rheumatic disease. J Clin Pathol 54:340\u2013347. https:\/\/doi.org\/10.1136\/jcp.54.5.340","journal-title":"J Clin Pathol"},{"key":"4779_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5414\/NP301077","volume":"37","author":"S Lepreux","year":"2018","unstructured":"Lepreux S, Hainfellner JA, Vital A (2018) Idiopathic inflammatory myopathies overlapping with systemic diseases. Clin Neuropathol 37:6\u201315. https:\/\/doi.org\/10.5414\/NP301077","journal-title":"Clin Neuropathol"},{"key":"4779_CR10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","volume":"78","author":"S Rothwell","year":"2019","unstructured":"Rothwell S, Chinoy H, Lamb JA et al (2019) Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups. Ann Rheum Dis 78:996\u20131002. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215046","journal-title":"Ann Rheum Dis"},{"key":"4779_CR11","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/rheumatology\/kep248","volume":"48","author":"H Chinoy","year":"2009","unstructured":"Chinoy H, Payne D, Poulton KV et al (2009) HLA\u2013DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology 48:1213\u20131217. https:\/\/doi.org\/10.1093\/rheumatology\/kep248","journal-title":"Rheumatology"},{"key":"4779_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3899\/jrheum.090652","volume":"37","author":"J-C Lega","year":"2010","unstructured":"Lega J-C, Cottin V, Fabien N et al (2010) Interstitial lung disease associated with Anti-PM\/Scl or Anti-Aminoacyl-tRNA synthetase autoantibodies: a similar condition? J Rheumatol 37:1000\u20131009. https:\/\/doi.org\/10.3899\/jrheum.090652","journal-title":"J Rheumatol"},{"key":"4779_CR13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/1756-185X.13559","volume":"22","author":"L Nu\u00f1o-Nu\u00f1o","year":"2019","unstructured":"Nu\u00f1o-Nu\u00f1o L, Joven BE, Carreira PE et al (2019) Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry. Int J Rheum Dis 22:1393\u20131401. https:\/\/doi.org\/10.1111\/1756-185X.13559","journal-title":"Int J Rheum Dis"},{"key":"4779_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/injr.injr_40_19","volume":"14","author":"L Gupta","year":"2019","unstructured":"Gupta L, Appani S, Janardana R et al (2019) Meeting report: MyoIN\u2013Pan-India collaborative network for myositis research. Indian J Rheumatol 14:136. https:\/\/doi.org\/10.4103\/injr.injr_40_19","journal-title":"Indian J Rheumatol"},{"key":"4779_CR15","doi-asserted-by":"publisher","DOI":"10.4103\/injr.injr_95_20","author":"R Naveen","year":"2020","unstructured":"Naveen R, Anuja A, Rai M et al (2020) Development of the myocite biobank: Cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis. Indian J Rheumatol. https:\/\/doi.org\/10.4103\/injr.injr_95_20","journal-title":"Indian J Rheumatol"},{"key":"4779_CR16","doi-asserted-by":"publisher","unstructured":"Gupta L, Majumder S, Aggarwal A, et al. (Ahead of Print) Serum Fatty Acid\u2011Binding Protein 3 Levels Differentiate Active from. Indian J Rheumatol. Doi: https:\/\/doi.org\/10.4103\/injr.injr_57_20","DOI":"10.4103\/injr.injr_57_20"},{"key":"4779_CR17","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"4779_CR18","unstructured":"STROBE Statement: https:\/\/www.strobe-statement.org\/index.php?id=available-checklists. Accessed 13 Oct 2020"},{"key":"4779_CR19","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS et al (2012) Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"4779_CR20","doi-asserted-by":"publisher","first-page":"e9692030","DOI":"10.1155\/2020\/9692030","volume":"2020","author":"KJ John","year":"2020","unstructured":"John KJ, Sadiq M, George T et al (2020) Clinical and immunological profile of mixed connective tissue disease and a comparison of four diagnostic criteria. Int J Rheumatol 2020:e9692030. https:\/\/doi.org\/10.1155\/2020\/9692030","journal-title":"Int J Rheumatol"},{"key":"4779_CR21","first-page":"1944","volume":"40","author":"KAHN M-F,","year":"1990","unstructured":"KAHN M-F, (1990) Syndrome de sharp. Syndr Sharp 40:1944\u20131945","journal-title":"Syndr Sharp"},{"key":"4779_CR22","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 Classification criteria for systemic sclerosis: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative: ACR\/EULAR Classification Criteria for SSc. Arthritis Rheum 65:2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"4779_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1475-x","author":"M Le Goff","year":"2017","unstructured":"Le Goff M, Cornec D, Jousse-Joulin S et al (2017) Comparison of 2002 AECG and 2016 ACR\/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-017-1475-x","journal-title":"Arthritis Res Ther"},{"key":"4779_CR24","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138:1464\u20131474. https:\/\/doi.org\/10.1378\/chest.10-0180","journal-title":"Chest"},{"key":"4779_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/rheumatology\/kez238","volume":"59","author":"Y Kaneko","year":"2020","unstructured":"Kaneko Y, Nunokawa T, Taniguchi Y et al (2020) Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study. Rheumatology 59:112\u2013119. https:\/\/doi.org\/10.1093\/rheumatology\/kez238","journal-title":"Rheumatology"},{"key":"4779_CR26","doi-asserted-by":"publisher","unstructured":"Mehta P, Gupta L (2020) Combined case record forms for collaborative datasets of patients and controls of idiopathic inflammatory myopathies. Indian J Rheumatol Ahead of Print. Doi: https:\/\/doi.org\/10.4103\/injr.injr_56_20","DOI":"10.4103\/injr.injr_56_20"},{"key":"4779_CR27","doi-asserted-by":"publisher","first-page":"100013","DOI":"10.1016\/j.jtauto.2019.100013","volume":"2","author":"ACM Platteel","year":"2019","unstructured":"Platteel ACM, Wevers BA, Lim J et al (2019) Frequencies and clinical associations of myositis-related antibodies in The Netherlands: a one-year survey of all Dutch patients. J Transl Autoimmun 2:100013. https:\/\/doi.org\/10.1016\/j.jtauto.2019.100013","journal-title":"J Transl Autoimmun"},{"key":"4779_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V et al (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatol Oxf 43:49\u201354. https:\/\/doi.org\/10.1093\/rheumatology\/keg427","journal-title":"Rheumatol Oxf"},{"key":"4779_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","volume":"77","author":"JB Lilleker","year":"2018","unstructured":"Lilleker JB, Vencovsky J, Wang G et al (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77:30\u201339. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211868","journal-title":"Ann Rheum Dis"},{"key":"4779_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cca.2016.12.007","volume":"465","author":"W Yang","year":"2017","unstructured":"Yang W, Wang X, Zhang W et al (2017) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are 2 new inflammatory markers associated with pulmonary involvement and disease activity in patients with dermatomyositis. Clin Chim Acta Int J Clin Chem 465:11\u201316. https:\/\/doi.org\/10.1016\/j.cca.2016.12.007","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"4779_CR31","doi-asserted-by":"publisher","first-page":"e0190411","DOI":"10.1371\/journal.pone.0190411","volume":"13","author":"Y-J Ha","year":"2018","unstructured":"Ha Y-J, Hur J, Go DJ et al (2018) Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study. PLoS ONE 13:e0190411. https:\/\/doi.org\/10.1371\/journal.pone.0190411","journal-title":"PLoS ONE"},{"key":"4779_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/art.1780110405","volume":"11","author":"TA Medsger","year":"1968","unstructured":"Medsger TA, Rodnan GP, Moossy J, Vester JW (1968) Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum 11:554\u2013568. https:\/\/doi.org\/10.1002\/art.1780110405","journal-title":"Arthritis Rheum"},{"key":"4779_CR33","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/acr.23291","volume":"69","author":"JJ Paik","year":"2017","unstructured":"Paik JJ, Wigley FM, Shah AA et al (2017) Fibrosing myopathy in systemic sclerosis associates with higher mortality. Arthritis Care Res 69:1764\u20131770. https:\/\/doi.org\/10.1002\/acr.23291","journal-title":"Arthritis Care Res"},{"key":"4779_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24167","author":"JL Fairley","year":"2020","unstructured":"Fairley JL, Hansen D, Proudman S et al (2020) Clinical characteristics and survival in systemic sclerosis-mixed connective tissue disease and systemic sclerosis-overlap syndrome. Arthritis Care Res. https:\/\/doi.org\/10.1002\/acr.24167","journal-title":"Arthritis Care Res"},{"key":"4779_CR35","first-page":"S12","volume":"30","author":"RW Koschik","year":"2012","unstructured":"Koschik RW, Fertig N, Lucas MR et al (2012) Anti-PM-Scl antibody in patients with systemic sclerosis. Clin Exp Rheumatol 30:S12-16","journal-title":"Clin Exp Rheumatol"},{"key":"4779_CR36","doi-asserted-by":"publisher","unstructured":"Liang Y, Leng RX, Pan HF, Ye DQ (2017) Associated variables of myositis in systemic lupus erythematosus: a cross-sectional study. Med Sci Monit Int Med J Exp Clin Res 23:2543\u20132549. Doi: https:\/\/doi.org\/10.12659\/MSM.902016","DOI":"10.12659\/MSM.902016"},{"key":"4779_CR37","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/rheumatology\/36.10.1067","volume":"36","author":"MJ Garton","year":"1997","unstructured":"Garton MJ, Isenberg DA (1997) Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases. Rheumatology 36:1067\u20131074. https:\/\/doi.org\/10.1093\/rheumatology\/36.10.1067","journal-title":"Rheumatology"},{"key":"4779_CR38","doi-asserted-by":"publisher","first-page":"e0225516","DOI":"10.1371\/journal.pone.0225516","volume":"14","author":"N Jiang","year":"2019","unstructured":"Jiang N, Li M, Zhang M et al (2019) Chinese SLE Treatment and Research group (CSTAR) registry: clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus. PLoS ONE 14:e0225516. https:\/\/doi.org\/10.1371\/journal.pone.0225516","journal-title":"PLoS ONE"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04779-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-020-04779-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04779-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T14:49:36Z","timestamp":1617288576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-020-04779-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,10]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4779"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04779-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,10]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliances with ethnical standers"}},{"value":"R Naveen: none declared, Latika Gupta: none declared, Upendra Rathore: none declared, and Vikas Agarwal: none declared. The paper has been accepted as live oral presentation in APLAR 2020. Link:","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}